Health Condition 1: O240- Pre-existing type 1 diabetes mellitus, in pregnancy, childbirth and the puerperium Health Condition 2: O241- Pre-existing type 2 diabetes mellitus, in pregnancy, childbirth and the puerperium Health Condition 3: O243- Unspecified pre-existing diabetesmellitus in pregnancy, childbirth and the puerperium Health Condition 4: O244- Gestational diabetes mellitus Health Condition 5: O248- Other pre-existing diabetes mellitus in pregnancy, childbirth, and the puerperium Health
Conditions
Interventions
Intervention1: Sliding scale insulin regimen given in antenatal diabetic women with deranged blood sugar profile due to corticosteroids given for fetal lung maturity: Between 24-36 weeks steroid will
Sponsors
Jawaharlal Institute of Postgraduate Medical Education Research
Eligibility
Inclusion criteria
Inclusion criteria: Age more than 18 years All diabetic women between 26-34 weeks of gestation developing hyperglycemia when receiving corticosteroids for fetal lung maturity
Exclusion criteria
Exclusion criteria: Women already on corticosteroids for other medical disorders in pregnancy Women on beta mimetic drugs Active labour Diabetic ketoacidosis Infection like pyelonephritis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the proportion of women with poor glycemic control with 4 point blood sugar profile for 72 hours between sliding scale regimen versus buffered insulin in diabetic women receiving antenatal corticosteroids for fetal lung maturityTimepoint: From 72 hours after 1st dose of steroid administration every 4 hourly blood glucose level will be measured and assess glycemic control in both groups | — |
Secondary
| Measure | Time frame |
|---|---|
| Hypoglycemia episodes Incidence of ketoacidosisTimepoint: From 72 hours after 1st dose of steroid administration this outcome will be assessed | — |
Countries
India
Contacts
Public ContactDr Madhavi Dobariya
Jawaharlal Institute of Postgraduate Medical Education & Research
Outcome results
None listed